Cardiol Therapeutics
Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditis
EQS-News: Cardiol Therapeutics
![]() Contact DetailsProactive Canada Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com News Source: News Direct
16.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG. |
Language: | English |
Company: | Cardiol Therapeutics |
United States | |
ISIN: | CA14161Y2006 |
EQS News ID: | 1515789 |
End of News | EQS News Service |